Front-line HIV Drug-Resistance Testing Should be New Standard of Care for Untreated Patients

Armen Hareyan's picture
Advertisement

HIV Treatment

Brigham and Women's Hospital (BWH), a leader in HIV drug-resistance research, has now determined that testing HIV patients for drug resistance prior to beginning treatment both improves survival and is cost effective.

Advertisement